Highlights

[HONGSENG] Acquisitions on 22-Feb-2021


Stock [HONGSENG]: HONG SENG CONSOLIDATED BERHAD
Announcement Date 22-Feb-2021

Listing Date 23-Feb-2021
New type/class? No
Type Acquisitions
Details Acquisition of 32% of the equity interest in eMedAsia Sdn Bhd ("eMedAsia") by HS Bio Supplies Sdn Bhd (formerly known as HC MSC Sdn Bhd), a wholly-owned subsidiary of the Company ("Acquisition of 32% of the equity interest in eMedAsia")
No. of shares issued 3,000,000
Issue Price Malaysian Ringgit (MYR)  1.000
Par Value -   0.000
Total NOSH 546,207,322


  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

572  344  555 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FINTEC 0.035+0.005 
 MMAG 0.185-0.005 
 VSOLAR 0.02+0.005 
 EURO 1.10-0.11 
 MTOUCHE 0.090.00 
 SERBADK 0.625-0.005 
 HHHCORP 0.190.00 
 MRDIY 3.900.00 
 FOCUS 0.04+0.005 
 EDARAN 1.17+0.265 

FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Why China is excluded in G7 summit? Koon Yew Yin Koon Yew Yin's Blog
2. AT Current Share Price: RM0.07. 1st Target Price: RM0.134, 2nd Target Price: RM0.28, 3rd Target Price: RM0.80 Fundamental Analysis of AT(0072) as at June 17 2021
3. SMetric (0203): A secured technical buy? - 17 June 2021 - Sujibaby Sujibaby Stock-Talk
4. Serba Dinamik rombak struktur Lembaga Pengarah, lantik IIlyas Pakeer sebagai pengerusi Oil and Gas Malaysia News
5. Mplus Market Pulse - 17 Jun 2021 M+ Online Research Articles
6. Singapore sees first day rush for Sinovac vaccine; as 16 Covid-19 cases announced on Friday (June 18) Good Articles to Share
7. [转贴] [Video:浅谈EURO HOLDINGS BHD, EURO, 7208] - James的股票投资James Share Investing James的股票投资James Share Investing
8. [MUST READ] Important message for all investors who are planning to invest in AT or existing AT shareholders Important message for all investors who are planning to invest in AT or existing AT shareholders
PARTNERS & BROKERS